Loading company…
Munich-based company offering AI-driven tools that help pharmaceutical firms with real-world insights and patient engagement.
Temedica GmbH was founded in 2016 by Gloria Seibert, Pd Friedrich and Tom Feuerstein and sells AI-powered products, including Permea Insight Hub, Permea Disease Navigator and Patient Companion, to pharmaceutical companies. Clients use the tools for brand performance, patient adherence and real-world evidence, mainly in Europe and North America, with a focus on multiple sclerosis. The company raised EUR 25 million in a Series B round on August 26, 2022, led by Santo Venture Capital and MIG Verwaltungs AG, and has a stated valuation of EUR 67.11 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in